Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 January 2026Published: 23 June 2015
Lung cancer: diagnosis and management (NG122)Product type:GuidanceProgramme:NICE guidelineLast updated: 8 March 2024Published: 28 March 2019
Suspected Cancer: recognition and referral (update)Status:In development | In consultationProgramme:NICE guidelineConsultation end date: 2 February 2026Expected publication date: 25 March 2026
Durvalumab for adjuvant treatment of resectable non-small-cell lung cancer [ID1263]Status:In developmentProgramme:NICE guidelineExpected publication date: TBC